医学
前列腺癌
肿瘤科
前列腺
癌症研究
阉割
内科学
癌症
激素
作者
Oliver Sartor,Johann S. de Bono,Kim N.,Karim Fizazi,Ken Herrmann,Kambiz Rahbar,Scott T. Tagawa,Luke T. Nordquist,Nitin Vaishampayan,Ghassan El‐Haddad,Chandler H. Park,Tomasz M. Beer,Alison Armour,Wendy J. Pérez-Contreras,Michelle DeSilvio,Euloge Kpamegan,Germo Gericke,Richard A. Messmann,Michael J. Morris,Bernd J. Krause
标识
DOI：10.1056/nejmoa2107322
摘要
Metastatic castration-resistant prostate cancer remains fatal despite recent advances. Prostate-specific membrane antigen (PSMA) is highly expressed in metastatic castration-resistant prostate cancer. Lutetium-177 (177Lu)–PSMA-617 is a radioligand therapy that delivers beta-particle radiation to PSMA-expressing cells and the surrounding microenvironment.
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
科研小民工
pluto
SYLH
back you up
ceeray23
剑指东方是为谁
昏睡的蟠桃
痴情的博超
默默地读文献
HEIKU
佰斯特威
踏实无敌
子车茗
Cactus
Cat
nino
图图
nebula
CGY
皖公网安备34019202002308
